Skip to content

Bioequivalence clinical trial of two formulations of vortioxetine.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519398-21-00
Acronym
N-VOT-24-292
Enrollment
30
Registered
2024-12-20
Start date
2025-01-30
Completion date
2025-04-04
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Sponsors

Laboratorios Normon S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026